Instytut MSF

Lodz, Lódzkie 90-302

0 studies enrolling now · 1 studies all time

What they study most

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation

Studies at this site

• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling